ABCA1 and cancer: Similar observations have been made regarding ABCA1 suppression in triple-negative breast cancers [21,22], and together with the current study, indicate that for cancers that thrive in cholesterol-rich environments, disrupting cholesterol efflux may be a viable therapeutic strategy.